In build — join the waitlist
Money should not be the reason you stop trying.
GivePanda is building one place to pay for family building. Raise from your community, borrow on terms that were written for a treatment cycle rather than a car, or buy a multi-cycle plan that refunds you if it does not work.
The medicine is solved. The money is not.
Fertility care is priced per cycle, and almost nobody needs exactly one. Coverage is patchy and depends more on your employer than your diagnosis. So the bill arrives as a lump sum, at the worst possible moment, to a household already spending its evenings on injections and appointments.
What people reach for instead: a credit card, a 401(k) loan, a parent, a crowdfunding page built for disaster relief. Every one of those is a workaround. None of them were designed for a cost that is planned, repeatable, and has a real chance of not working the first time.
That is a financing problem. We are building the financing.
Three ways to pay for it, under one roof.
Most families end up using more than one. They should not have to assemble it from three unrelated companies.
- First
Community fundraising
Raise from the people already rooting for you.
A campaign built for a story that is private, medical, and usually long — not one engineered to go viral. Share it with the twenty people who matter instead of the internet.
- Next
Treatment financing
One application, real offers.
A marketplace where lenders and clinic payment plans compete for your cycle, so the fallback is not a credit card at whatever rate it happens to carry.
- Then
Multi-cycle packages
Buy the outcome, not the appointment.
Bundled plans that cover several cycles at a known price, with money back if you do not end up taking a baby home. The risk sits with us, not with you.
Clinics, pharmacies, agencies
Every patient who walks away over price is a treatment room sitting empty. We want to hand you funded patients and take the payment conversation off your front desk. If you run a practice or an agency and want to be part of the first cohort, join the list and tell us who you are when we reach out.
We are building this now.
Leave your email and we will tell you once — when there is something real to use. Not a newsletter.